Document Detail


Erectile dysfunction after PlasmaKinetic vaporization of the prostate: incidence and risk factors.
MedLine Citation:
PMID:  16999629     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: To determine the incidence of erectile dysfunction (ED) after PlasmaKinetic vaporization of the prostate (PKVP) using objective and subjective parameters and risk factors. PATIENTS AND METHODS: A total of 153 men completed a questionnaire detailing perceived sexual dysfunction and underwent nocturnal penile-tumescence testing using the RigiScan for three consecutive nights 3 or 4 days preoperatively and 3 months postoperatively. The International Index of Erectile Function (IIEF)-5 scores were obtained preoperatively and postoperatively. Full details of each operation were recorded, including grams of tissue resected, operative time, any short-term complications, especially emphasizing capsular perforation, and concomitant diseases such as diabetes and hypertension. The association of risk factors with the development of ED after PKVP was assessed. Complete data were available for 103 men (67.3%). Their mean age was 62.1 years (range 48-83 years). RESULTS: Postoperatively, 11 patients (10.6%) were found to have ED. Patients who developed ED postoperatively had a lower IIEF-5 score and penile-tumescence parameters preoperatively (for all parameters, P < 0.0001). As risk factors, diabetes, capsular perforation, and an IIEF-5 score <21 were found to be significant. CONCLUSIONS: The incidence of ED after PKVP measured objectively was 10.6%. In the absence of the risk factors, PKVP is a safe therapeutic strategy with regard to sexual function.
Authors:
Xiaoyong Pu; Xinghuan Wang; Huaipeng Wang; Liquan Hu
Related Documents :
17320669 - Cryoablation as primary treatment for localized prostate cancer followed by penile reha...
1281729 - Use of terazosin in the medical treatment of benign prostatic hyperplasia: experience i...
18231739 - Sonablate-500 transrectal high-intensity focused ultrasound (hifu) for benign prostatic...
15711109 - Pre-surgical finasteride therapy in patients treated endoscopically for benign prostati...
12131309 - Is periprostatic local anesthesia for transrectal ultrasound guided prostate biopsy ass...
9187689 - Transurethral needle ablation (tuna) of the prostate: a clinical and urodynamic evaluat...
12026339 - Oral meperidine, atropine, and pentobarbital for pediatric conscious sedation.
23542829 - Lymphatic microsurgery to treat lymphedema: techniques and indications for better results.
2282349 - Temporal response of leukocyte accumulation in the thoracic cavity after two types of s...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of endourology / Endourological Society     Volume:  20     ISSN:  0892-7790     ISO Abbreviation:  J. Endourol.     Publication Date:  2006 Sep 
Date Detail:
Created Date:  2006-09-26     Completed Date:  2007-01-09     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8807503     Medline TA:  J Endourol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  693-7     Citation Subset:  IM    
Affiliation:
The Center of Urology and Andrology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, PRC. pxyandrol@163.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Catheter Ablation / adverse effects*,  instrumentation
Diabetes Complications
Erectile Dysfunction / etiology*
Humans
Male
Middle Aged
Prostatic Hyperplasia / surgery
Questionnaires
Risk Factors
Volatilization

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Focal prostate cryoablation: initial results show cancer control and potency preservation.
Next Document:  Endocytoscopy: novel endoscopic imaging technology for in-situ observation of bladder cancer cells.